Indication · General & Plastic Surgery
Acne, psoriasis and other skin conditions
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
189
Cleared or approved since 2000
PMA and De Novo
2
Higher-risk or first-of-kind devices
Breakthrough devices
0
Authorized through June 30, 2026
Recruiting device trials
27
406 device trials in all
Devices
0 devices via PMA. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
No devices on this pathway.
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
- Evaluating Pulsed Dye Laser Treatment Parameters on Clearance of Vascular IndicationsEnrolling by invitation
University of California, IrvineAcademic, hospital or other
NCT07949747 · 25 participants (planned) · Start Jul 6, 2026 · Primary completion Dec 2028
Device: Laser with DCD Pre- and Post-Cooling; Laser with Standard DCD Pre-Cooling Only · For: Rosacea; Scars; Port Wine Capillary Malformations
Sites: Irvine, California
405 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
- Light, Ultraviolet, Dermatological (FTC)63
- Over-The-Counter Powered Light Based Laser For Acne (OLP)48
- Device, Iontophoresis, Other Uses (EGJ)37
- Lasers For Temporary Increase Of Clear Nail In Patients With Onychomycosis (PDZ)19
- Powered Light Based Non-Laser Surgical Instrument (ONE)7
- Light Based Treatment For Cold Sores Herpes Simplex Virus-1 (OKJ)4
- Autoantibodies, Skin (Bullous Pemphigoid 180 And Bullous Pemphigoid 230 (OEG)3
- Autoantibodies, Skin (Desmoglein 1 And Desmoglein 3) (NBO)2
- Laser Absorbing Particles (QCY)2
- Instrument For Treatment Of Hyperhidrosis (OUB)1
- Over The Counter Thermal Treatment For Acne. (OZC)1
- Skin Patch For Treatment Of Hyperhidrosis (QVX)1
- Ultraviolet Lamp Products (SGZ)1
Research
- Device studies on acne across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.